The Relationship Between Costs and Quality in Veterans Health Administration Nursing Homes
Empirical Approach: In this study, we use preliminary 2005 to 2007 data to examine the relationship between costs and quality in 112 nursing homes, called community living centers by the VA. We are extending this data through 2012 so that we can perform better longitudinal cost/quality comparisons. A set of 24 quality indicators (QIs), which measures unfavorable events (e.g. falls) or patient states (e.g., depression), has been developed from the Minimum Data Set (MDS) to measure the quality of nursing home care. Four of the QIs are stratified into high and low risk categories, resulting in a total of 28 QIs. We used a multivariate normal distribution to model these rates with a 28 dimension multivariate normal distribution with mean vector γ and covariance matrix Σ. We specified a non-informative multivariate normal prior for the mean vector γ and used a Wishart distribution for the inverse of the covariance matrix T = Σ-1 WinBUGs. The data consisted of the following variables for each of the 112 facilities for each of the 3 fiscal years in our preliminary analysis: total patient days in the year, total costs during the year, quality score based on the last MDS assessment done in the year and Resource Utilization Groups (RUGs) score, calculated as “number of days in each RUGs category during the year times the RUG category relative weight” divided by the “total number of days”. In order to adjust for facility clustering over time, we used generalized estimating equations (GEE) with an exchangeable correlation matrix. We considered two link functions: a linear link with a normal error and a log link with a gamma error.
Preliminary Results: Robust to a number of sensitivity tests, we find that increases in the MDS-based quality score (interpreted as lower quality) are associated with higher costs. Holding everything else constant, a 0.022 increase in quality score (about 1 SD, and interpreted as a decrease in quality since, as noted, these are adverse events) is associated with a 6.56% increase in cost.